Shares of biotechnology company Amgen Inc. closed the week at $53.08 a share. AMGN stock price is near the key technical levels of $53.58 (50 day moving average) and $54.54 (200 day moving average).
Amgen has a market capitalization of $49.49 billion and a current price to earnings ratio of 11.07.
Amgen's products include Aranesp (darbepoetin alfa), and NEUPOGEN (Filgrastim), EPOGEN (Epoetin alfa), and Neulasta (pegfilgrastim).
Amgen Inc.
Shares of biotechnology company Amgen (stock symbol AMGN) closed the week at $55.42 a share.
AMGN stock price has traded between 52wk low of $50.26 and a 52 week high of $61.26 a share.
Amgen's products include Aranesp and EPOGEN, Neulasta and NEUPOGEN, Enbrel, Sensipar/Mimpara, and Vectibix.
AMGN stock price quote Amgen Inc
Shares of Thousand Oaks, California based Amgen are currently trading at $51.38 per share. AMGN, a biotechnology giant with over 17,000 employees is trading just above the 52 week low of $50.32 a share. AMGN's 52 week high is $64.76.
Amgen is led by CEO Kevin W. Sharer, President and COO Robert A. Bradway, and executive Vice Presidents Dr. Fabrizio J. Bonanni, Mr. George J. Morrow, and Dr. Roger M. Perlmutter M.D., Ph.D.
